Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04933851 · ClinicalTrials.gov registry record · Phase 2

ACT1VATE: Addressing Emotional Distress to Improve Outcomes Among Diverse Adults With Type 1 Diabetes

A Phase 2 study of Type 1 Diabetes, sponsored by Scripps Whittier Diabetes Institute.

Recruiting
Registry status
Phase 2
Development phase
250
Enrollment target
1
Study location

NCT04933851 is a Phase 2 study of Type 1 Diabetes that is actively recruiting participants, run by Scripps Whittier Diabetes Institute. The registered enrollment target is 250 participants, below the 823-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04933851, a Phase 2 study of Type 1 Diabetes, is actively recruiting participants, sponsored by Scripps Whittier Diabetes Institute.

RECRUITING
Registry status
Phase 2
Development phase
250 participants
Enrollment target
1
Study location

Study Summary

This research will compare a psychological intervention ("ACT1VATE") versus diabetes self-management education and support (DSME/S; usual care) in improving clinical, behavioral, psychosocial, process, and cost outcomes among adults with poorly controlled type 1 diabetes (T1D) who are experiencing significant diabetes-related emotional distress and poor glycemic control in a real world, healthcare environment.

Conditions Studied

Interventions

  • BEHAVIORAL ACT1VATE
  • BEHAVIORAL DSME/S

Study Locations (1)

California

  • Scripps Whittier Diabetes Institute - San Diego

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2021-10-25
Est. Completion 2027-03-31
Phase Phase 2

What the Registry Record Tells You About NCT04933851

The ClinicalTrials.gov registry entry for NCT04933851 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 823-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (70% lower). The listed sponsor is Scripps Whittier Diabetes Institute, which has 17 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 1 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which ACT1VATE is the first listed.

NCT04933851 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04933851 about?

NCT04933851 is a clinical study titled "ACT1VATE: Addressing Emotional Distress to Improve Outcomes Among Diverse Adults With Type 1 Diabetes". This research will compare a psychological intervention ("ACT1VATE") versus diabetes self-management education and support (DSME/S; usual care) in improving clinical, behavioral, psychosocial, process, and cost outcomes among adults with poorly controlled type 1 diabetes (T1D) who are experiencing s...

What is the current status of trial NCT04933851?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 250 participants. The study started on 2021-10-25. Estimated completion is 2027-03-31.

What conditions does trial NCT04933851 study?

This clinical trial studies the following conditions: Type 1 Diabetes.

What interventions are being tested in trial NCT04933851?

The interventions under investigation include: ACT1VATE (BEHAVIORAL), DSME/S (BEHAVIORAL).

Who is sponsoring clinical trial NCT04933851?

This trial is sponsored by Scripps Whittier Diabetes Institute, which has 17 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04933851 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 1 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.